MINI FUTURE LONG - MERCK & CO. Share Price

Certificat

DE000MD9LSN3

Market Closed - Bid/Ask 09:39:28 27/06/2024 pm IST After market 12:40:53 am
2.97 EUR -9.73% Intraday chart for MINI FUTURE LONG - MERCK & CO. 3.005 +1.18%
Current month+25.10%
1 month+7.87%
Date Price Change
27/24/27 2.97 -9.73%
26/24/26 3.29 -3.24%
25/24/25 3.4 +0.89%
24/24/24 3.37 +8.01%
21/24/21 3.12 +1.30%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 09:39 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MD9LSN
ISINDE000MD9LSN3
Date issued 20/10/2022
Strike 96.79 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.84
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.47
Lowest since issue 0.67
Spread 0.01
Spread %0.33%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.50%
Consensus